|
Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA …
PR Newswire (press release) While AR itself is not life-threatening (unless accompanied by severe asthma or anaphylaxis), morbidity associated with the condition can be significant. … |
View full post on asthma – Google News